Plasma platelet activating factor-acetylhydrolase (PAF-AH).
about
Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activityLipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complicationsRegulation of the Golgi complex by phospholipid remodeling enzymesPhospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic interventionThe role of platelet-activating factor in mesangial pathophysiologyPhospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizationsYY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2.Relationship between platelet activating factor acetylhydrolase activity and apolipoprotein B levels in patients with peanut allergy.A novel platelet-activating factor acetylhydrolase discovered in a metagenome from the earthworm-associated microbial community.Circulating and PBMC Lp-PLA2 associate differently with oxidative stress and subclinical inflammation in nonobese women (menopausal status).Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolaseThe metabolic serine hydrolases and their functions in mammalian physiology and disease.cDNA cloning and expression pattern of homolog of alpha subunit of platelet-activating factor acetylhydrolase Ib from the Chinese oak silkworm, Antheraea pernyi.Platelet-activating factor is a potent pyrogen and cryogen, but it does not mediate lipopolysaccharide fever or hypothermia.Association of lipoprotein-associated phospholipase A2 with coronary calcification among American and Japanese menCorrelation between plasma lipoprotein-associated phospholipase A2 and peripheral arterial disease.Lipoprotein-associated phospholipase A2 and risk of venous thrombosis in older adults.Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella.Darapladib: an emerging therapy for atherosclerosis.The Role of Phospholipase A(2)-derived Mediators in Obesity.Coenzyme-A-Independent Transacylation System; Possible Involvement of Phospholipase A2 in Transacylation.Platelet-activating factor-acetylhydrolase can monodeacylate and inactivate lipoteichoic acid.Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation.Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection.The effects of hyperoxia exposure on lung function and pulmonary surfactant in a rat model of acute lung injury.Platelet activating factor induces transient blood-brain barrier opening to facilitate edaravone penetration into the brain.Altered lipoprotein subclass distribution and PAF-AH activity in subjects with generalized aggressive periodontitis.Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians.Effect of platelet-activating factor (PAF) receptor antagonist (BN52021) on acetaminophen-induced acute liver injury and regeneration in rats.The pathophysiology of anaphylaxis.
P2860
Q24541516-B7D6A3AF-F43F-4AD8-A364-147C23976561Q26777871-478F6C20-48C9-4F52-88F2-7DFB50D0DB00Q26995761-ACF96B79-A410-496C-B3CF-4A2F1B9C62DFQ26997377-E6D493F9-A67D-4B9C-9A93-EE4C996D7C21Q28081511-A33705FD-F617-4272-BCD4-5E6DF055B45DQ28286551-C40274D0-B8C7-4DE1-8748-802BAB0003EEQ30847206-716C35B6-7BAB-4E07-ABF2-F8D8CFEF0E99Q33575941-9A78859B-5677-4E02-BE1D-1D57306C0001Q34020871-59F12CC7-14AD-4D42-BDB6-7FAD2ADD2230Q34167997-1EAB4BE0-7865-40FE-BCFD-58D89B9E9B48Q34541071-6613B388-5AD9-41DB-9853-E95918236BC1Q34670677-21ED6421-77B8-4476-88D0-4C0A3B45C924Q35333042-D7EC95CB-C45C-4915-AAA4-932A1B189538Q35762125-C13C576A-CE9B-436D-811D-4B738901C17BQ36832729-9A1A2A0D-C243-46AD-9193-50213265FED4Q36861883-39C64F58-26B5-4887-BE62-2B5D2FF66A5FQ36900840-FEF743EF-8B03-4479-B2ED-2C2B9A371A3DQ37001368-E5CB225C-E4A6-4548-990E-1FE6BE40886BQ37430645-DE41798D-21DC-4005-B72A-07F0A41AF67BQ37775820-EF6F00AA-6C59-40E1-9B92-ACEA8B8D267AQ37878270-C2264173-4307-402A-98F0-C8A694C25036Q39208689-8ED6EACD-2D72-45E3-A7BE-8FDDF5FB1CD7Q40294302-4B628E3F-C2B5-4903-8039-C7A3518754FEQ42563701-5D3AE5A7-986E-482C-9A9E-4E99507E035EQ43035003-ED293A0F-71B9-498F-A0F5-EBB3A2BBF1F1Q43258292-2A5E2D1E-F8C9-44BA-90F9-13B2087AD78DQ44610359-69E095EF-270C-4B9C-838F-BBC74A88FE71Q44913770-4126F02C-5066-4ED3-91D8-C2BA07A6F217Q46631117-7FC5CE57-4459-4983-9BEA-46E3B153ABD4Q46899603-C6E3AE79-E655-4359-913C-DF10E9D0F03EQ47810222-BF93F157-BC8E-4EC7-BF03-529BD67F6445
P2860
Plasma platelet activating factor-acetylhydrolase (PAF-AH).
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Plasma platelet activating factor-acetylhydrolase (PAF-AH).
@ast
Plasma platelet activating factor-acetylhydrolase (PAF-AH).
@en
type
label
Plasma platelet activating factor-acetylhydrolase (PAF-AH).
@ast
Plasma platelet activating factor-acetylhydrolase (PAF-AH).
@en
prefLabel
Plasma platelet activating factor-acetylhydrolase (PAF-AH).
@ast
Plasma platelet activating factor-acetylhydrolase (PAF-AH).
@en
P2093
P1476
Plasma platelet activating factor-acetylhydrolase (PAF-AH).
@en
P2093
Ayako Harada
Keizo Inoue
Ken Karasawa
Morio Setaka
Noriko Satoh
P304
P356
10.1016/S0163-7827(02)00049-8
P577
2003-03-01T00:00:00Z